All sponsors

Biotheus Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS10
PHASE 3 / 2-32
RECRUITING2
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO30%

Delay Index: of 10 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Biotheus Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
PM8002
NCT05844150
P2Active, not recruitingSCLC502024-05-10 (-13 mo)
PM8002
NCT05756972
P2Active, not recruitingNSCLC642024-09-13 (-6 mo)
PM8002
NCT05879068
P2Active, not recruitingSCLC992025-04-30 (+12 mo)
PM8002
NCT05918445
P1/2RecruitingMalignant Neoplasm3802025-11-30 (+24 mo)
PM8002
NCT06584071
P1/2Not yet recruitingHCC; Liver Cancer1402026-10
PM8002
NCT05918133
P1/2Active, not recruitingTNBC422026-10-30
PM8002
NCT05879055
P2Active, not recruitingNeuroendocrine Neoplasm312027-01-01
PM8002
NCT07133750
P2RecruitingCRC (Colorectal Cancer)1002027-05 (+9 mo)
PM8002
NCT06616532
P3Active, not recruitingSCLC4042027-05 (+3 mo)
PM8002
NCT06419621
P3Active, not recruitingTriple Negative Breast Cancer(TNBC)3922027-07